Wikidata entity: Q1758380
C₁₈H₃₇N₅O₉ (P274)
Quantities
| P2067 | mass | 467.259 |
| P3780 | active ingredient in | ... | Q47521260 (Bethkis) | Bethkis |
| P3780 | active ingredient in | ... | Q47522211 (Tobi) | Tobi |
| P3780 | active ingredient in | ... | Q47522213 (Tobrex) | Tobrex |
| P3780 | active ingredient in | ... | Q48828297 (Kitabis) | Kitabis |
| P3780 | active ingredient in | ... | Q29006573 (Tobi Podhaler) | Tobi Podhaler |
| P3780 | active ingredient in | ... | Q29006630 (Vantobra) | Vantobra |
| P233 | canonical SMILES | String | C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N | ??? |
| P373 | Commons category | String | Tobramycin | ??? |
| P703 | found in taxon | ... | Q134359 (Aspergillus fumigatus) | Aspergillus fumigatus |
| P703 | found in taxon | ... | Q22287126 (Streptomyces cremeus) | Streptomyces cremeus |
| P703 | found in taxon | ... | Q26285164 (Serratia plymuthica) | Serratia plymuthica |
| P703 | found in taxon | ... | Q26289014 (Streptoalloteichus hindustanus) | Streptoalloteichus hindustanus |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N | ??? |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P176 | manufacturer | ... | Q206921 (Pfizer) | Pfizer |
| P2175 | medical condition treated | ... | Q12192 (pneumonia) | pneumonia |
| P2175 | medical condition treated | ... | Q178194 (cystic fibrosis) | cystic fibrosis |
| P2175 | medical condition treated | ... | Q221668 (urinary tract infection) | urinary tract infection |
| P2175 | medical condition treated | ... | Q167844 (conjunctivitis) | conjunctivitis |
| P2175 | medical condition treated | ... | Q32778 (bronchiectasis) | bronchiectasis |
| P2175 | medical condition treated | ... | Q34879 (staphylococcal infection) | staphylococcal infection |
| P2175 | medical condition treated | ... | Q7255052 (Pseudomonas infection) | Pseudomonas infection |
| P2175 | medical condition treated | ... | Q19597369 (gram-negative bacterial infection) | gram-negative bacterial infection |
| P2175 | medical condition treated | ... | Q727028 (bacterial infectious disease) | bacterial infectious disease |
| P2175 | medical condition treated | ... | Q2622199 (upper respiratory tract infection) | upper respiratory tract infection |
| P361 | part of | ... | Q22277948 (tobramycin metabolic process) | tobramycin metabolic process |
| P361 | part of | ... | Q22277956 (tobramycin biosynthetic process) | tobramycin biosynthetic process |
| P361 | part of | ... | Q22277963 (tobramycin catabolic process) | tobramycin catabolic process |
| P769 | significant drug interaction | ... | Q185331 (rocuronium) | rocuronium |
| P769 | significant drug interaction | ... | Q275926 (bumetanide) | bumetanide |
| P769 | significant drug interaction | ... | Q367700 (cyclosporine) | cyclosporine |
| P769 | significant drug interaction | ... | Q388801 (furosemide) | furosemide |
| P769 | significant drug interaction | ... | Q420387 (foscarnet) | foscarnet |
| P769 | significant drug interaction | ... | Q424027 (vancomycin) | vancomycin |
| P769 | significant drug interaction | ... | Q424378 (succinylcholine) | succinylcholine |
| P769 | significant drug interaction | ... | Q81978749 (cisatracurium) | cisatracurium |
| P769 | significant drug interaction | ... | Q412415 (cisplatin) | cisplatin |
| P769 | significant drug interaction | ... | Q413877 (mivacurium) | mivacurium |
| P769 | significant drug interaction | ... | Q415588 (carboplatin) | carboplatin |
| P769 | significant drug interaction | ... | Q27098039 (atracurium) | atracurium |
| P279 | subclass of | ... | Q12140 (medication) | medication |
| P279 | subclass of | ... | Q28742 (aminoglycoside) | aminoglycoside |
| P2868 | subject has role | ... | Q12187 (antibiotic) | antibiotic |
| P2868 | subject has role | ... | Q45355603 (aminoglycoside antibiotic) | aminoglycoside antibiotic |
| P2868 | subject has role | ... | Q7251505 (protein synthesis inhibitor) | protein synthesis inhibitor |
| P12081 | WHO Aware Classification | ... | Q122925721 (watch) | watch |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | tobramycin | ??? |
| P267 | ATC code | J01GB01 |
| P267 | ATC code | S01AA12 |
| P231 | CAS Registry Number | 32986-56-4 |
| P683 | ChEBI ID | 28864 |
| P592 | ChEMBL ID | CHEMBL1747 |
| P661 | ChemSpider ID | 33377 |
| P715 | DrugBank ID | DB00684 |
| P11198 | DrugCentral ID | 2684 |
| P8494 | DSSTOX compound identifier | DTXCID903680 |
| P3117 | DSSTox substance ID | DTXSID8023680 |
| P232 | EC number | 251-322-5 |
| P2566 | ECHA Substance Infocard ID | 100.046.642 |
| P646 | Freebase ID | /m/07jj92 |
| P595 | Guide to Pharmacology Ligand ID | 10930 |
| P2062 | HSDB ID | 3259 |
| P2057 | Human Metabolome Database ID | HMDB0014822 |
| P234 | InChI | InChI=1S/C18H37N5O9/c19-3-9-8(25)2-7(22)17(29-9)31-15-5(20)1-6(21)16(14(15)28)32-18-13(27)11(23)12(26)10(4-24)30-18/h5-18,24-28H,1-4,19-23H2/t5-,6+,7+,8-,9+,10+,11-,12+,13+,14-,15+,16-,17+,18+/m0/s1 |
| P235 | InChIKey | NLVFBUXFDBBNBW-PBSUHMDJSA-N |
| P665 | KEGG ID | D00063 |
| P244 | Library of Congress authority ID | sh85135762 |
| P10245 | MedlinePlus drug identifier | a681003 |
| P10245 | MedlinePlus drug identifier | a682660 |
| P486 | MeSH descriptor ID | D014031 |
| P672 | MeSH tree code | D09.408.051.476.600.800 |
| P6366 | Microsoft Academic ID (discontinued) | 2778974779 |
| P8189 | National Library of Israel J9U ID | 987007538920705171 |
| P7746 | Natural Product Atlas ID | NPA024722 |
| P2115 | NDF-RT ID | N0000146911 |
| P2840 | NSC number | 180514 |
| P2840 | NSC number | 757352 |
| P10283 | OpenAlex ID | C2778974779 |
| P3636 | PDB ligand ID | TOY |
| P638 | PDB structure ID | 4LFC |
| P638 | PDB structure ID | 3SG8 |
| P638 | PDB structure ID | 1LC4 |
| P638 | PDB structure ID | 4JD6 |
| P638 | PDB structure ID | 1M4D |
| P638 | PDB structure ID | 5CFS |
| P638 | PDB structure ID | 4XJE |
| P638 | PDB structure ID | 4EBK |
| P638 | PDB structure ID | 4EVY |
| P638 | PDB structure ID | 3VET |
| P11199 | Probes And Drugs ID | PD001728 |
| P662 | PubChem CID | 36294 |
| P1579 | Reaxys registry number | 1357507 |
| P3345 | RxNorm CUI | 10627 |
| P4964 | SPLASH | splash10-03di-0911100000-b28142c63090941c9e87 |
| P2877 | SureChEMBL ID | 2838 |
| P2892 | UMLS CUI | C0040341 |
| P11089 | UniChem compound ID | 404692 |
| P652 | UNII | VZ8RRZ51VK |
| P11143 | WikiProjectMed ID | Tobramycin |
| P8814 | WordNet 3.1 Synset ID | 04450722-n |
| P3350 | World Health Organisation international non-proprietary name numeric ID | 2990 |
Why not click here or view trends?
log id: 1851450